Brooklyn FI LLC Makes New $5.82 Million Investment in Agilent Technologies, Inc. (NYSE:A)

Brooklyn FI LLC acquired a new stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 42,496 shares of the medical research company's stock, valued at approximately $5,822,000.

A number of other institutional investors also recently added to or reduced their stakes in A. Flynn Zito Capital Management LLC grew its stake in shares of Agilent Technologies by 3.8% during the fourth quarter. Flynn Zito Capital Management LLC now owns 1,871 shares of the medical research company's stock worth $251,000 after acquiring an additional 69 shares during the last quarter. IFP Advisors Inc raised its position in shares of Agilent Technologies by 17.7% in the 4th quarter. IFP Advisors Inc now owns 458 shares of the medical research company's stock valued at $62,000 after purchasing an additional 69 shares during the last quarter. Tiemann Investment Advisors LLC raised its position in shares of Agilent Technologies by 5.6% in the 4th quarter. Tiemann Investment Advisors LLC now owns 1,423 shares of the medical research company's stock valued at $191,000 after purchasing an additional 75 shares during the last quarter. Rothschild Investment LLC raised its position in shares of Agilent Technologies by 19.2% in the 4th quarter. Rothschild Investment LLC now owns 491 shares of the medical research company's stock valued at $66,000 after purchasing an additional 79 shares during the last quarter. Finally, CIBC Private Wealth Group LLC raised its position in shares of Agilent Technologies by 1.2% in the 4th quarter. CIBC Private Wealth Group LLC now owns 7,479 shares of the medical research company's stock valued at $1,025,000 after purchasing an additional 87 shares during the last quarter.

Agilent Technologies Trading Down 1.3%

Shares of NYSE A traded down $1.45 during mid-day trading on Friday, reaching $111.83. 4,751,122 shares of the company's stock were exchanged, compared to its average volume of 1,943,133. The firm has a market capitalization of $31.88 billion, a price-to-earnings ratio of 27.61, a PEG ratio of 3.17 and a beta of 1.27. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.66 and a current ratio of 2.09. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $153.84. The company's 50-day moving average is $108.44 and its 200-day moving average is $126.47.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings results on Wednesday, May 28th. The medical research company reported $1.31 earnings per share for the quarter, topping analysts' consensus estimates of $1.26 by $0.05. The business had revenue of $1.67 billion during the quarter, compared to analysts' expectations of $1.63 billion. Agilent Technologies had a return on equity of 25.92% and a net margin of 17.59%. The company's revenue was up 6.0% compared to the same quarter last year. During the same period in the prior year, the business posted $1.22 EPS. Analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 23rd. Investors of record on Tuesday, July 1st will be paid a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a yield of 0.89%. The ex-dividend date of this dividend is Tuesday, July 1st. Agilent Technologies's payout ratio is 24.44%.

Insider Buying and Selling

In other Agilent Technologies news, VP Rodney Gonsalves sold 1,908 shares of the stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $121.98, for a total value of $232,737.84. Following the sale, the vice president now owns 21,786 shares of the company's stock, valued at $2,657,456.28. This trade represents a 8.05% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Daniel K. Podolsky sold 1,819 shares of the stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $116.46, for a total value of $211,840.74. Following the completion of the sale, the director now directly owns 35,737 shares in the company, valued at $4,161,931.02. This represents a 4.84% decrease in their position. The disclosure for this sale can be found here.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the company. Barclays decreased their target price on Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating for the company in a report on Thursday, April 10th. Robert W. Baird decreased their target price on Agilent Technologies from $159.00 to $140.00 and set an "outperform" rating for the company in a report on Thursday, May 22nd. UBS Group decreased their target price on Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating for the company in a report on Thursday. TD Cowen lifted their target price on Agilent Technologies to $150.00 and gave the stock a "buy" rating in a report on Thursday. Finally, Leerink Partners lifted their target price on Agilent Technologies to $135.00 and gave the stock a "buy" rating in a report on Friday. Seven research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $140.15.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.